Evidence map›Paper›PMID 37005201›Full record

ArticleEBioMedicine2023

Multi-modal profiling of peripheral blood cells across the human lifespan reveals distinct immune cell signatures of aging and longevity.

Tanya T Karagiannis, Todd W Dowrey, Carlos Villacorta-Martin, Monty Montano, Eric Reed, Anna C Belkina, Stacy L Andersen, Thomas T Perls, Stefano Monti, George J Murphy and 1 more

Open access · goldAbstract read
In one paragraph

Article in EBioMedicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
12.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Review
  3. The long-lived immune system of centenarians.Nature reviews. Immunology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Osteoblast-CD4Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Tanya T KaragiannisInstitute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA. Electronic address: tkaragiannis@tuftsmedicalcenter.org.
Todd W DowreyCenter for Regenerative Medicine (CReM), Boston University and Boston Medical Center, Boston, MA, USA.
Carlos Villacorta-MartinCenter for Regenerative Medicine (CReM), Boston University and Boston Medical Center, Boston, MA, USA.
Monty MontanoDepartment of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Boston Pepper Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Eric ReedData Intensive Study Center, Tufts University, Boston, MA, USA.
Anna C BelkinaDepartment of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA, USA; Flow Cytometry Core Facility, Boston University School of Medicine, Boston, MA, USA.
Stacy L AndersenDepartment of Medicine, Geriatrics Section, Boston University School of Medicine, Boston, MA, USA.
Thomas T PerlsDepartment of Medicine, Geriatrics Section, Boston University School of Medicine, Boston, MA, USA.
Stefano MontiBioinformatics Program, Boston University, Boston, MA, USA; Division of Computational Biomedicine, Boston University School of Medicine, Boston, MA, USA; Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
George J MurphyCenter for Regenerative Medicine (CReM), Boston University and Boston Medical Center, Boston, MA, USA; Section of Hematology and Medical Oncology, Boston University School of Medicine, Boston, MA, USA.
Paola SebastianiInstitute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA; Department of Medicine, Tufts University, Boston, MA, USA.
Boston University · USTufts University · USBrigham and Women's Hospital · USTufts Medical Center · US

Funding

Systems BiologyU19AG023122 · NIA · TRANSLATIONAL GENOMICS RESEARCH INST · PI RICHARD A MILLER · 2004 to 2026
$102.6M
TUFTS--FIELDINGP30AG031679 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI SHALENDER BHASIN · 2008 to 2026
$23.9M
Identifying protective omics profiles in centenarians and translating these into preventive and therapeutic strategiesUH3AG064704 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI PERLS, THOMAS T, SEBASTIANI, PAOLA · 2022 to 2025
$14.7M
Identifying protective omics profiles in centenarians and translating these into preventive and therapeutic strategiesUH2AG064704 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI PERLS, THOMAS T, SEBASTIANI, PAOLA · 2019 to 2021
$9.4M
MoFlo Astrios EQ High Speed Cell SorterS10OD021587 · OD · BOSTON UNIVERSITY MEDICAL CAMPUS · PI SNYDER-CAPPIONE, JENNIFER E · 2017 to 2017
$600k
NIA NIH HHS P30 AG031679NIA NIH HHS U19 AG023122NIA NIH HHS UH2 AG064704NIA NIH HHS UH3 AG064704NIH HHS S10 OD021587
6 · The paper itself

Abstract

backgroundAge-related changes in immune cell composition and functionality are associated with multimorbidity and mortality. However, many centenarians delay the onset of aging-related disease suggesting the presence of elite immunity that remains highly functional at extreme old age.

methodsTo identify immune-specific patterns of aging and extreme human longevity, we analyzed novel single cell profiles from the peripheral blood mononuclear cells (PBMCs) of a random sample of 7 centenarians (mean age 106) and publicly available single cell RNA-sequencing (scRNA-seq) datasets that included an additional 7 centenarians as well as 52 people at younger ages (20-89 years).

findingsThe analysis confirmed known shifts in the ratio of lymphocytes to myeloid cells, and noncytotoxic to cytotoxic cell distributions with aging, but also identified significant shifts from CD4

interpretationCollectively, these data suggest that centenarians harbor unique, highly functional immune systems that have successfully adapted to a history of insults allowing for the achievement of exceptional longevity.

fundingTK, SM, PS, GM, SA, TP are supported by NIH-NIAUH2AG064704 and U19AG023122. MM and PS are supported by NIHNIA Pepper center: P30 AG031679-10. This project is supported by the Flow Cytometry Core Facility at BUSM. FCCF is funded by the NIH Instrumentation grant: S10 OD021587.

Indexed as

Leukocytes, MononuclearLongevityAdultAgedAged, 80 and overAgingApoptosis Regulatory ProteinsHumansMiddle AgedProtein Serine-Threonine KinasesYoung AdultApoptosis Regulatory ProteinsProtein Serine-Threonine KinasesSTK17A protein, humanAgingElite immunityExtreme human longevitySingle cell RNA sequencing

Identifiers

PMID37005201
PMCPMC10114155
OpenAlexW4362466820

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.